7-benzyl-5,6,7,8-tetrahydro-2-(morpholin-4-yl)-4H-pyrido[4',3':4,5]thieno[2,3-d][1,3]oxazin-4-one

ID: ALA106681

Chembl Id: CHEMBL106681

PubChem CID: 11538212

Max Phase: Preclinical

Molecular Formula: C20H21N3O3S

Molecular Weight: 383.47

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1oc(N2CCOCC2)nc2sc3c(c12)CCN(Cc1ccccc1)C3

Standard InChI:  InChI=1S/C20H21N3O3S/c24-19-17-15-6-7-22(12-14-4-2-1-3-5-14)13-16(15)27-18(17)21-20(26-19)23-8-10-25-11-9-23/h1-5H,6-13H2

Standard InChI Key:  RVGOQDHSICIQEZ-UHFFFAOYSA-N

Associated Targets(non-human)

CEL Cholesterol esterase (67 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ache Acetylcholinesterase (12221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 383.47Molecular Weight (Monoisotopic): 383.1304AlogP: 2.64#Rotatable Bonds: 3
Polar Surface Area: 58.81Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.66CX LogP: 3.33CX LogD: 3.26
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.69Np Likeness Score: -1.72

References

1. Pietsch M, Gütschow M..  (2005)  Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition.,  48  (26): [PMID:16366609] [10.1021/jm0508639]

Source